Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Urology|June 23, 2020
Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab after Failure of Prior Tyrosine Kinase InhibitorsKosuke Takemura, Takeshi Yuasa, Ryo Fujiwara, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2021
Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long-term outcomes after gastrectomyNobutoshi Horii, Takashi Kosaka, Ryo Fujiwara, et al.
Frontiers in Plant Science|January 28, 2022
Convolutional Neural Network Models Help Effectively Estimate Legume Coverage in Grass-Legume Mixed SwardsRyo Fujiwara, Hiroyuki Nashida, Midori Fukushima, et al.
Cureus|April 10, 2025
Exploratory Investigation of Barriers to Writing Case Reports Among Japanese Physicians Who Participated in Web Study SessionsTsuneaki Kenzaka, Shinsuke Yahata, Naoya Mizutani, et al.
Nano Letters|January 5, 2019
Near-Infrared Lasing at 1 μm from a Dilute-Nitride-Based Multishell NanowireShula Chen, Mitsuki Yukimune, Ryo Fujiwara, et al.
Expert Review of Anticancer Therapy|May 30, 2024
Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative reviewMartin Zarba, Ryo Fujiwara, Takeshi Yuasa, et al.
Anticancer Research|October 28, 2020
Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell CancerShotaro Yasuoka, Takeshi Yuasa, Ryo Fujiwara, et al.
Cancer Reports (Hoboken, N.J.)|May 2, 2021
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in JapanMotohiro Fujiwara, Takeshi Yuasa, Tetsuya Urasaki, et al.
Expert Review of Anticancer Therapy|April 10, 2025
Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative reviewRyosuke Oki, Kosuke Takemura, Tetsuya Urasaki, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Switching Patients With Prostate Cancer from GnRH Antagonist to Long-acting LHRH Agonist for Androgen Deprivation: Reducing Hospital Visits During the Coronavirus PandemicMotohiro Fujiwara, Takeshi Yuasa, Yoshinobu Komai, et al.
Pageof 6